| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Nov 2025 | 4 Nov 2025 |
| Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve the Un-Audited Standalone & Consolidated Financial Results of the Company for the Second Quarter and Half Year ended September 30 2025. please find enclosed (As per BSE Announcement dated on: 14.11.2025) | ||
| Board Meeting | 26 Aug 2025 | 26 Aug 2025 |
| Please find enclosed outcome of the Board Meeting | ||
| Board Meeting | 12 Aug 2025 | 6 Aug 2025 |
| Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve the Un-Audited Standalone & Consolidated Financial Results of the Company for the First Quarter ended June 30 2025. Please find enclosed outcome of board meeting (As per BSE Announcement Dated on 12/08/2025) | ||
| Board Meeting | 2 Jul 2025 | 2 Jul 2025 |
| Please find enclosed Outcome of Board Meeting | ||
| Board Meeting | 11 Jun 2025 | 11 Jun 2025 |
| Please find enclosed outcome of the Board Meeting | ||
| Board Meeting | 19 May 2025 | 13 May 2025 |
| Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 inter alia to consider and approve Audited Standalone & Consolidated Financial Results of the Company for the Fourth Quarter and Year ended March 31 2025 Please find enclosed Outcome of the Board Meeting (As Per BSE Announcement Dated on: 19/05/2025) | ||
| Board Meeting | 9 Jan 2025 | 2 Jan 2025 |
| VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2025 inter alia to consider and approve the Un-Audited Standalone & Consolidated Financial Results of the Company for the Third Quarter and Nine Months ended December 31 2024. Outcome of the Board Meeting Issue of Securities (As Per Bse Announcement Dated on 09.01.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.